Nuclear Medicine Market Expected To Trigger A Revenue To USD 15.2 Billion By 2025 : Grand View Research Inc.
San Francisco, 14 August 2019: The Report Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 – 2025 The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a 10.1% CAGR during the forecast period. The burden of chronic diseases such as cancer and cardiac disorders is on a rise. Nuclear medicine is widely used for diagnosis as well as treatment of such disorders. Increasing prevalence of these disorders has a direct impact on usage of radiopharmaceuticals. As per data published by the World Health Organization (WHO), cancer is the second leading cause of death around the globe and in 2015, accounted for 8.8 million deaths. This is anticipated to drive demand for radiopharmaceuticals in the years to come. Diagnostics, w